Fischer Medical Ventures Ltd.
National Stock Exchange of IndiaTotal Valuation
Fischer Medical Ventures Ltd. carries a market capitalization of 24.82B, placing it among publicly traded companies globally.
| Market Cap | 24.82B |
| Enterprise Value | N/A |
Financial Position
Fischer Medical Ventures Ltd. maintains a current ratio of 6.39, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 27.05, indicating elevated leverage, while an interest coverage ratio of 5.56 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 6.39 |
| Quick Ratio | 3.32 |
| Debt / Equity | 27.05 |
| Debt / EBITDA | N/A |
| Interest Coverage | 5.56 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1.53 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Fischer Medical Ventures Ltd. has paid 60.02M in income taxes, reflecting an effective tax rate of 48.71.
| Income Tax | 60.02M |
| Effective Tax Rate | 48.71 |
Stock Price Statistics
Fischer Medical Ventures Ltd.'s stock has declined approximately -51.12142% over the past 52 weeks. The 50-day moving average sits at 36.33, while the 200-day moving average is 49.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.12142% |
| 50-Day Moving Average | 36.33 |
| 200-Day Moving Average | 49.67 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Fischer Medical Ventures Ltd. generated 1.24B in revenue and converted that into 63.20M in net income, yielding earnings per share of 0.11. EBITDA reached 56.28M, while operating income came in at 56.28M.
| Revenue | 1.24B |
| Gross Profit | 282.83M |
| Operating Income | 56.28M |
| Pretax Income | 123.22M |
| Net Income | 63.20M |
| EBITDA | 56.28M |
| EBIT | 56.28M |
| Earnings Per Share (EPS) | 0.11 |
Margins
Fischer Medical Ventures Ltd. operates with a gross margin of 22.81, reflecting its pricing power and cost economics. The operating margin of 4.54 and net profit margin of 5.10 provide insight into operational efficiency.
| Gross Margin | 22.81 |
| Operating Margin | 4.54 |
| Pretax Margin | 9.94 |
| Profit Margin | 5.10 |
| EBITDA Margin | 4.54 |
Scores
Fischer Medical Ventures Ltd. posts an Altman Z-Score of 2.03, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.03 |